POLICY DEEP DIVE · AFFORDABILITY · ACCESS

The Part-Time Job: Making Your Pharmacy Benefit Work for You

For many patients, the pharmacy benefit works quietly in the background. For others, managing it has become a part-time job: hours on the phone, prior authorization renewals, and prices nobody can explain until the counter. Pharmacy benefit managers, employers, and patients want many of the same fixes. Here is where we agree, what is changing, and how you can be heard.

pharmacy counter patient and pharmacist

The Problem

PBMs sit between the medicine your doctor prescribes and the price you pay at the counter. For many patients it works well, and they barely notice it. When it doesn't, patients spend hours on the phone, repeat approvals for medicines they have taken for years, and learn what they owe only when the pharmacist rings it up.

What's Changing

In 2026, Congress passed major PBM reforms and the Department of Labor finalized new fee disclosure rules for employer plans. Employers will see full reporting on rebates and fees, and Medicare will pay PBMs for their service rather than as a share of a drug's price. Most of it phases in between 2027 and 2029, so patients won't feel much of it right away.

Where We Agree

Patients, PBMs, and employers want many of the same things: real prices before the counter, faster prior authorization, pharmacists who can do more, and lower-cost competition that actually reaches patients. This Deep Dive starts there and gives you two ways to be heard.

THE BASICS

What a PBM Does

A pharmacy benefit manager runs the prescription drug part of a health plan for whoever pays for that plan: an employer, an insurer, a union, or a Medicare or Medicaid plan. Four of its jobs shape your experience most directly. It builds the formulary, the list of covered medicines and the tier each one sits on. It runs utilization management, including prior authorization and step therapy. It builds the pharmacy network that decides where you can fill a prescription. And it negotiates with manufacturers for rebates and discounts in exchange for favorable formulary placement.

That last job is where much of the confusion starts. A rebate lowers what the plan pays, but your coinsurance and your deductible are often calculated on the drug's list price, before any rebate. That is why a reform can lower what a plan spends without changing what a patient pays. At Patients Rising we put it simply: a price is not a cost. A lower price only counts if it reaches the counter.

Drug_Channel_System-Jan2016
JUNE 2026 TOWN HALL

Where This Conversation Started

In June 2026, Patients Rising hosted a town hall with senior leaders of the Pharmaceutical Care Management Association (PCMA), the trade association for PBMs, and put patients' questions to them directly. Decisions about pharmacy benefits have long been made in rooms patients weren't invited into, and this was a chance to change that. The conversation was candid on both sides. PCMA's Dave Marin acknowledged that the association had not been the partner many needed, "and most importantly, patients." PCMA's Tim Dube said of prior authorization renewals, "We need to get better at that," and pointed out that doctors' offices still use fax machines to request prior authorizations: "that's got to stop."

Those are openings worth building on, and this Deep Dive is where we track them. Patients asked more questions than the hour allowed. We have asked PCMA to answer them in writing, and we will publish those answers here, in PCMA's own words, when they arrive. Since then, PCMA has told us it wants to engage with patient groups differently, by understanding each other's perspectives, finding common ground, and working together where it can. We welcome that, and this page is where we will keep track of how it goes.

THE CALENDAR

What's Changing, and When

The 2026 reforms are real, but most of them change the contracts between PBMs and the people who hire them before they change anything at the counter. Here is the calendar.

WhenWhat changesWhat it means for patients
February 2026Congress enacts PBM reforms in the Consolidated Appropriations Act, 2026, signed February 3.The law is set; most provisions take effect later.
February–July 2026The FTC settles its insulin case with Express Scripts and CVS Caremark, and later OptumRx.Settlement terms include passing rebates through so more patients pay a lower price at the counter.
August 2026Nine PBMs commit to show TrumpRx cash prices in their real-time benefit and pricing tools.Patients should be able to compare an insured price with a cash price. Too early to judge results.
October 29, 2026The Department of Labor finalizes its PBM fee disclosure rule. PBMs serving self-insured employer plans must disclose their compensation, including manufacturer rebates and fees and spread pricing, before signing a contract and twice a year after, and plans gain the right to audit. It applies to plan years starting on or after July 1, 2027.Employers get a clearer view of what their PBM earns. These disclosures go to the plan, not to patients, so the question is still whether savings reach the counter.
November 4, 2026CVS Health announces plans to split into two public companies. Aetna, the Caremark PBM, and CVS Specialty stay together, while retail and mail pharmacy and MinuteClinic become a separate company called CVS Pharmacy. The split is expected by 2028.Nothing changes at the counter today. Over time, patients should watch whether pharmacy networks, mail-order options, and prices change as the two companies separate.
Now through December 15, 2026CMS takes comments on a proposed rule implementing the Medicare Part D PBM provisions of the 2026 law.Patients can weigh in on how the Medicare rules are written.
2028Medicare Part D plans must let any willing pharmacy that meets standard terms join their networks.More choice of pharmacy, including independent and community pharmacies.
Plan years starting on or after August 3, 2028 (January 1, 2029 for most employer plans)Employer plans receive semiannual reports on drug spending, rebates, and PBM pay; 100% of rebates pass through to the plan; plans can audit their PBM each year.Your employer will finally see the full picture. Whether savings reach you depends on how your employer designs the plan.
Phasing in over the next few yearsMedicare PBM pay delinked from list prices and replaced with flat service fees.Removes an incentive to favor higher-priced medicines.

The thread running through that calendar is important for patients. Rebates passing through to an employer is not the same as savings reaching a patient. An employer can choose to apply discounts at the point of sale, lower cost-sharing, or keep premiums down, and those are choices patients and employees can ask about.

OUR PATIENT PRINCIPLES

Where Patients and PBMs Can Agree

These are the principles Patients Rising brings to pharmacy benefit policy. Several of them overlap with ideas PCMA has put forward publicly in its Path to Patient Affordability, and that overlap is where we think progress can come fastest. Our test for every one is the same: does it change what a patient experiences at the doctor's office, in the app, and at the counter?

1. Show patients the real price before they reach the counter. Real-time benefit tools already exist, and PBMs are expanding them. To work for patients, they have to show what this patient will actually pay, including where they stand on their deductible and whether copay assistance will count. And they should be available at the pharmacy and in the patient's own app, not only in the prescriber's office.

2. Prior authorization with a patient clock. Electronic prior authorization is far faster than fax and phone, and it should be the norm everywhere. Beyond speed, patients who are stable on a therapy shouldn't have to re-prove their need every year, and patients who change plans shouldn't have to start over. A renewal standard for stable patients and a transition period that honors existing approvals when coverage changes would remove much of the part-time job.

3. Savings should reach the counter. When cost-sharing is calculated on a list price that no one in the system actually pays, the patient is the one left paying it. We support applying negotiated discounts at the point of sale, and we will help patients and employees ask their plans whether that is happening. The new law gives employers the information to make that choice; we want them to make it.

4. Let pharmacists do more, and let patients choose their pharmacy. Pharmacists are some of the most accessible and most underused health professionals in the country. We support paying pharmacists for clinical services within the scope of their training, and pharmacy networks that keep trusted community pharmacies within reach.

5. Competition that reaches the patient. We welcome lower-cost generics and biosimilars, and we want them on formularies quickly so patients actually benefit. For patients who are stable on a treatment, a switch should be a clinical decision made with their prescriber, and both the patient and the prescriber should be told when a change is made.

6. Transparency that runs in every direction. Patients deserve to see how the system works. Reporting on rebates, discounts, fees, ownership, and financial relationships should apply evenly across the entire drug supply chain, so no part of it is a black box.

7. Judge conduct, not structure. Patients Rising doesn't support breaking up companies because of how they are organized. Integration can serve patients, and it can be abused. We focus on practices that help or harm patients, wherever they occur. CVS Health's November 2026 plan to separate its retail pharmacies from Caremark and Aetna is a good test of that principle. What matters for patients is not how the companies are organized, but whether prices, pharmacy choice, and access improve at the counter.

8. A real peer for every peer review. When a treatment is denied, the doctor who reviews the decision should practice in the same field as the doctor who prescribed it. A patient's cancer treatment plan deserves a reviewer who treats cancer. Accreditation standards from NCQA already call for a same-or-similar specialist to review appeals that require a medical necessity decision. The work now is making that promise hold for patients: applying it from the first denial rather than only after a formal appeal, checking that it happens case by case, and telling patients and their doctors the specialty of the person who reviewed their case. PCMA has offered to help connect patients with the accreditation bodies that set these standards, and we intend to take them up on it.

PBM TOOLS FOR PATIENTS

Know Before the Counter

You shouldn't need a second job to fill a prescription. These five steps can save hours, and they work whether your coverage comes through an employer, the marketplace, or Medicare.

Check your price before you leave the doctor's office. Ask your prescriber to check your real-time benefit, which shows whether a medicine is covered, what you will owe, and whether a lower-cost covered option exists. Then check your plan's app or website, which often shows the same information. If the numbers don't match what you are charged at the pharmacy, write down both and ask why.

Ask the four coverage questions. Is this medicine on my formulary? What tier is it on? Does it need prior authorization or step therapy? Is there a quantity limit? Knowing the answers before the pharmacy calls can save days.

If prior authorization is denied, ask for it in writing. Your denial notice should explain the reason and your appeal deadline. Ask your prescriber to request a peer-to-peer review with the plan's reviewer, and ask what specialty that reviewer practices, and file an appeal if the answer is still no. Keep a log of every call, the date, and the name of the person you spoke with.

Changing plans? Ask about a transition fill. If you are stable on a medicine and your new plan doesn't cover it, ask whether you qualify for a temporary supply while you request an exception. Medicare Part D plans are required to provide a transition fill to eligible new enrollees during their first 90 days; if your coverage comes through an employer, ask whether your plan has a similar policy.

Ask whether your copay assistance counts. If you use manufacturer or charitable copay assistance, ask your plan whether those payments count toward your deductible and out-of-pocket maximum. Some plans count them, and some don't. Knowing which applies to you can prevent a surprise bill later in the year.

BE HEARD

Ask Your PBM

Have a question about how your pharmacy benefit works? Ask it here. Patients Rising gathers the questions patients send us, groups the most common ones, and brings them to the people who run pharmacy benefits, including PCMA. When we receive answers, we will post them on this page in the respondents' own words, so everyone can learn from them. We will never share your name or contact information without your permission.

[Ask Your PBM form embeds here.]

YOUR STORY

Share Your Story

Policy changes when decision-makers can see what a rule does to a real person, and that cuts both ways. For many patients, the pharmacy benefit works: a new prescription is approved quickly, a refill arrives on time, or one call to the plan solves the problem. Those stories matter, because knowing what works is how we argue for more of it. If you have spent hours on a prior authorization, been switched off a medicine that was working, or found out at the counter that you owed far more than you expected, your story can help change the rules. Whatever your experience, good or bad, we want to hear it.

STATE OF THE PATIENT

Listen: Episode 9

In June, the leaders of the PBM industry's trade association sat down with patients. Four months later, we went back to ask what has changed for the people doing the part-time job, and for the people whose benefit works. Episode 9 of State of the Patient brings together PCMA's Brendan Buck, patients, and moments from the June town hall to ask what the next chapter of PBM reform should do for patients.

[Episode 9 player embeds here.]